Netdex (Netilmicin Sulfate, Dexamethasone Disodium Phosphate)

Netilmicin sulfate and dexamethasone disodium phosphate, the active ingredients in Netdex, are an aminoglycoside antibiotic and a corticosteroid presented as an ophthalmic solution for ocular use. They treat bacterial eye infections and inflammatory ocular conditions. GNH USA supplies Netdex as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Netdex is indicated for bacterial and inflammatory eye conditions, acting as both an antimicrobial and anti‑inflammatory agent.

Bacterial conjunctivitis: reduces bacterial load and resolves infection. Keratitis: eliminates causative bacteria and promotes corneal healing. Post‑operative ocular inflammation: suppresses inflammatory response and alleviates pain and swelling.

Adverse reactions may occur with ocular administration of Netdex.

Common Side Effects: - Transient eye irritation: mild burning or stinging on instillation. - Blurred vision: temporary reduced visual acuity. - Increased tear production: watery eyes. - Conjunctival hyperemia: mild redness.

Serious or Rare Side Effects: - Allergic contact dermatitis: severe itching, swelling, or rash. - Secondary ocular infection: overgrowth of resistant organisms. - Elevated intraocular pressure: sustained pressure rise requiring monitoring. - Corneal ulceration: rare but serious corneal damage.

Use Netdex with caution and follow professional guidance. - Allergy assessment: avoid if known hypersensitivity to aminoglycosides or corticosteroids. - Contact lens use: discontinue lenses before and after application. - Systemic absorption: limit use to prescribed duration to reduce systemic exposure. - Pregnancy and lactation: use only if benefit outweighs risk, as safety data are limited. - Monitoring intraocular pressure: assess patients with glaucoma or steroid responders. - Store at room temperature: keep in original container, protect from light and moisture.

Consider potential drug interactions when prescribing Netdex.

Major Interactions (Avoid): - Systemic aminoglycosides: concurrent use may increase ototoxicity and nephrotoxicity. - Other ocular corticosteroids: additive risk of increased intraocular pressure. - Topical NSAIDs: may enhance corneal toxicity.

Moderate Interactions (Monitor Closely): - Anticholinergic eye drops: may reduce drug absorption. - Beta‑blocker eye drops: monitor for additive ocular hypotensive effects. - Herbal eye preparations: potential for unpredictable interactions.